U.S. Beverage Stock News

NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

Appeals Court Win on Disclosure Lawsuit Could Be A Game Changer For DLocal (DLO)

On 20 April 2026, DLocal Limited reported that the New York Appellate Division unanimously upheld the full dismissal of a securities class action alleging misleading disclosures about trends in its take rate. The appellate court’s finding that plaintiffs failed to identify a known material trend, given DLocal’s reported TPV, revenue, and gross profit growth, removes a significant legal overhang for investors assessing disclosure risk. We’ll now examine how this appellate affirmation of the...
NYSE:DX
NYSE:DXMortgage REITs

Dynex Capital Award Highlights Risk Controls Portfolio Shift And Shareholder Focus

Dynex Capital (NYSE:DX) has received a major corporate citizenship award from The Conference Board for its leadership in sustainability and ethical stewardship. The company has adjusted its risk management approach, including changes in its mortgage backed securities portfolio and lower exposure to callable agency MBS. Management is aligning parts of the portfolio with government led policy trends that influence mortgage and housing related assets. For investors tracking NYSE:DX, the...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape (QS) Valuation Revisited After Adding Lockheed Martin Commercialization Leader To Advisory Board

QuantumScape (QS) has drawn fresh investor attention after adding Dr. Mark Maybury, a senior Lockheed Martin technology and commercialization leader, to its strategic advisory board. This move raises questions about how his experience could influence future product rollout. See our latest analysis for QuantumScape. The recent board appointment and upcoming Q1 2026 earnings update on 22 April arrive after a 5.92% 1 month share price return. However, a 36.89% year to date share price decline...
NYSE:SQM
NYSE:SQMChemicals

Is It Too Late To Consider Sociedad Química y Minera de Chile (NYSE:SQM) After 147% One Year Gain?

Investors may be wondering whether Sociedad Química y Minera de Chile's current share price still leaves room for value, or if most of the opportunity is already reflected in the market. The stock last closed at US$87.22, with returns of 22.6% over 30 days, 25.1% year to date, 147.1% over 1 year, 38.6% over 3 years, and 81.9% over 5 years. Over the past 7 days, the share price has declined by 1.9%. Recent attention on Sociedad Química y Minera de Chile has centered on its role as a major...
NYSE:FIX
NYSE:FIXConstruction

Comfort Systems USA Rides Data Center Boom With Record Margins And Backlog

Comfort Systems USA (NYSE:FIX) is taking on a central role in large data center construction, winning sizable technology focused mechanical and electrical projects. The company reports record margins and rapid growth in technology related project backlog tied to data center expansion. This shift is reshaping Comfort Systems USA’s business mix toward core digital infrastructure work. For investors watching the build out of digital infrastructure, Comfort Systems USA now sits closer to the...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

Is It Time To Reassess WeRide (WRD) After Recent Autonomous Driving Headlines?

If you are wondering whether WeRide at around US$8.10 is a bargain or a value trap, the starting point is to understand what the current price implies about the business. The stock has moved 2.5% over the last 7 days and 27.6% over the last 30 days, although the return so far this year sits at a 13.7% decline and the 1 year return is a 7.8% decline. Recent coverage has focused on WeRide's position within autonomous driving and auto technology, as investors weigh how its products fit into...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart Faces Antitrust Scrutiny While Expanding Healthcare And Supplier Programs

Walmart (NasdaqGS:WMT) is cited in newly unsealed California court filings in an Amazon antitrust case that alleges coordinated price increases across major U.S. retailers. The filings claim Amazon pushed vendors such as Levi's, Hanes, and Newell Brands to raise prices at retailers including Walmart and Target to limit undercutting on its platform. Separately, Walmart is expanding its Better Care Services platform to include GLP-1 weight-management support, extending its healthcare reach. In...
NYSE:TYL
NYSE:TYLSoftware

Is Tyler Technologies (TYL) Still Attractive After A 39.4% One Year Share Price Decline

If you are wondering whether Tyler Technologies at around US$341 a share still makes sense for a long term portfolio, the key question is what you are really paying for today. The stock has had a mixed run, with a 5.9% gain over the last 7 days, a 2.5% decline over 30 days, and year to date and 1 year returns of 21.7% and 39.4% declines respectively. These moves have kept investors focused on what is already priced into Tyler Technologies and whether the market is rethinking the level of...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

A Look At Akamai Technologies (AKAM) Valuation After Recent Share Price Momentum Rebuild

Why Akamai Technologies Stock Is On Investors’ Radar Akamai Technologies (AKAM) is drawing fresh attention after recent trading activity highlighted a mixed return profile, with gains over the past year set against a decline over the past month. See our latest analysis for Akamai Technologies. The latest share price of $98.08 comes after a 10.40% 7 day share price return that follows a 30 day share price return of 11.22% and a 1 year total shareholder return of 33.13%, suggesting recent...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Oncology Pivot In Focus As ASCO 2026 Data And PADCEV Loom

Pfizer (NYSE:PFE) plans to unveil major oncology pipeline updates at the ASCO 2026 Annual Meeting. The company will present new clinical data across its cancer portfolio, including LORBRENA, BRAFTOVI, TALZENNA, and TUKYSA. Pfizer will also highlight early and late stage pipeline assets that expand its presence in multiple tumor types. For investors tracking Pfizer, the ASCO 2026 update is an important moment in the company’s effort to reposition itself around oncology rather than COVID...
NYSE:DELL
NYSE:DELLTech

Is Dell (DELL) Quietly Recasting Its Role In Mission-Critical Infrastructure With Vertical-Focused Push?

Dell Technologies recently showcased its industrial and vertical-specific solutions at Hannover Messe 2026 in Hannover, Germany, complemented by defense-focused participation at the Sea Air Space 2026 conference in Maryland. These appearances highlight Dell's push to position its infrastructure and product-management capabilities more directly within manufacturing and government ecosystems, potentially reinforcing its relevance in complex, mission-critical workloads. We’ll now examine how...
NYSE:EPD
NYSE:EPDOil and Gas

Is Enterprise Products Partners (EPD) Pricing Reflect Its Strong Multi‑Year Return Performance?

If you are wondering whether Enterprise Products Partners at around US$37.21 is offering fair value or a margin of safety, the next sections will walk through what the current price may be implying. The unit price has seen a small 0.1% decline over the last week and a 0.9% decline over the last month, while the year to date return sits at 15.7% and the 1 year return at 29.8%, with 3 year and 5 year returns of 72.9% and 130.1% respectively. Recent coverage has focused on the partnership's...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

A Look At ACI Worldwide (ACIW) Valuation As Fair Value Signals A Possible Discount

ACI Worldwide (ACIW) is back in focus after recent trading left the stock around $44.22, with returns mixed across different periods and investors weighing its payment software and biller-focused revenue profile. See our latest analysis for ACI Worldwide. The recent pullback to a 1 day share price return of 2.06% follows a strong 7 day and 30 day share price rebound of 6.68% and 12.12% respectively. This comes alongside a weaker 1 year total shareholder return of 13.40%, but a much stronger 3...
NYSE:GWRE
NYSE:GWRESoftware

A Look At Guidewire Software’s Valuation After The Palisades AI Release And ProNavigator Launch

Guidewire Software (GWRE) has put AI at the center of its story with the Palisades release, introducing ProNavigator, an embedded assistant inside InsuranceSuite and InsuranceNow that surfaces governed, role specific insights directly in underwriting and claims workflows. See our latest analysis for Guidewire Software. The share price has been under pressure, with a 24.83% year to date share price decline and a 25.67% one year total shareholder return loss, even though the three year total...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

A Look At Webull (BULL) Valuation As PDT Rule Support And Zero Commission Launch Draw New Attention

Why Webull is back on traders’ radar Webull (BULL) is drawing fresh attention after announcing support for upcoming changes to Pattern Day Trader rules, a new zero commission offer in Canada, and a US$100 million share repurchase program. See our latest analysis for Webull. The recent share repurchase plan, support for upcoming Pattern Day Trader rule changes, and the Canadian zero commission launch have coincided with a sharp 7 day share price return of 20.62% and 30 day share price return...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Is Fulton Financial (FULT) Still Attractive After 40% One‑Year Share Price Gain?

Wondering if Fulton Financial at a last close of US$21.86 is still offering value or if the easy gains are already on the table? This breakdown is designed to help you frame that question clearly. The stock has delivered returns of 0.6% over 7 days, 11.4% over 30 days, 12.3% year to date and 40.2% over 1 year, with a 110.2% return over 3 years and 54.9% over 5 years that will catch many investors' attention. Recent share price moves are set against ongoing interest in US regional banks and...
NYSE:W
NYSE:WSpecialty Retail

Does Rising Earnings Optimism Around Wayfair (W) Reveal Deeper Shifts In Its Profit Narrative?

In the past week, analysts highlighted Wayfair’s history of beating earnings estimates and its current positive Earnings ESP of 9.80%, reflecting growing optimism ahead of the upcoming quarterly report. This renewed bullishness on earnings, combined with Wayfair’s recent track record of delivering upside surprises, is reshaping how investors assess its near-term profit potential. Next, we’ll examine how this rising analyst confidence in Wayfair’s earnings prospects interacts with the...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

How Millicom’s New 2032 Notes and Subsea Deal At Millicom International Cellular (TIGO) Has Changed Its Investment Story

Earlier in April 2026, Millicom International Cellular completed a US$87.5 million reopening of its 7.375% senior notes due 2032 via a Regulation S private placement, while also entering a long-term commercial agreement with Trans Americas Fiber System to boost its subsea network capacity across Central America. This combination of new fixed-income funding and access to a next‑generation, high‑capacity subsea fiber platform could reshape Millicom’s capital allocation and infrastructure...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

Is G-III Apparel Group (GIII) Pricing Reflecting Its Strong Recent Share Price Performance

If you are wondering whether G-III Apparel Group at around US$31.90 is offering good value today, the key is to compare the recent share performance with what the fundamentals might justify. The stock has posted returns of 8.3% over the last 7 days, 19.7% over 30 days, 8.1% year to date and 30.0% over 1 year, with a 3 year return of 110.6% and a 5 year return of 3.8%. Recent coverage has focused on how fashion brands are positioning themselves with wholesalers and retailers. It has also...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics (DGX) Margin And EPS Rebound Reinforce Bullish Narratives In Q1 2026

Quest Diagnostics (DGX) opened Q1 2026 with total revenue of US$2.9 billion and basic EPS of US$2.29, setting the tone for how the new year is starting to shape up for the testing giant. Over recent quarters the company has seen revenue move from US$2.6 billion in Q1 2025 to US$2.9 billion in Q1 2026, while basic EPS shifted from US$1.97 to US$2.29. This gives investors a clear view of how the top and bottom lines are tracking through the most recent reporting stretch. With a trailing twelve...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic (ESTC) Is Up 6.6% After New AI Integrations And Google Cloud Award - Has The Bull Case Changed?

In April 2026, Elastic announced MCP Apps for Elastic, bringing agent-native security, observability, and search workflows directly into third-party AI tools like Claude, GitHub Copilot, and VS Code, and it was also named 2026 Google Cloud Partner of the Year in the Marketplace category for Data Management & AI. Together, these moves highlight Elastic’s push to embed its search and AI capabilities inside widely used cloud and developer ecosystems, potentially deepening how often and how...
NYSE:EPAM
NYSE:EPAMIT

A Look At EPAM Systems (EPAM) Valuation As Earnings Optimism Builds Ahead Of May 7 Results

EPAM Systems (EPAM) heads into its May 7 pre market first quarter 2026 earnings release with attention on the company’s projected diluted EPS of US$2, which implies 14.9% profit growth versus the prior year period. See our latest analysis for EPAM Systems. At a share price of US$132.12, EPAM has seen short term strength, with a 7 day share price return of 3.7%, but that comes after a 90 day share price decline of 38.0% and a 5 year total shareholder return loss of 71.2%. This points to fading...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

What Xenon Pharmaceuticals (XENE)'s Positive Phase 3 X-TOLE2 Epilepsy Data Means For Shareholders

Xenon Pharmaceuticals recently presented positive Phase 3 X-TOLE2 data at the American Academy of Neurology 2026 meeting, showing azetukalner meaningfully reduced focal onset seizure frequency versus placebo in highly treatment-resistant adult patients. Multi-year open-label extension results and real-world survey data highlight azetukalner’s long-term seizure control and the potential practical benefit of a once-daily, no-titration epilepsy therapy for both patients and physicians. With...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Assessing SPS Commerce (SPSC) Valuation After A Challenging Year For Shareholder Returns

Recent performance context for SPS Commerce (SPSC) SPS Commerce (SPSC) has drawn investor attention after a difficult past year, with the stock showing a 56% decline over 12 months and weaker returns over the past 3 months and year to date. See our latest analysis for SPS Commerce. The recent bounce, with a 7 day share price return of 9.15%, sits against a much weaker 1 year total shareholder return of 55.78% and a 3 year total shareholder return of 59.46%. This suggests momentum has been...